Skip to main content
. Author manuscript; available in PMC: 2022 Apr 19.
Published in final edited form as: Cancer. 2021 Dec 6;128(5):1048–1056. doi: 10.1002/cncr.34011

Table 1.

Demographic characteristics of patients undergoing screening or diagnostic procedures for cancer in 2018–2020.

Year of Procedure
Variable 2018–2019 2020 P-value
N 1,618,014 (80.1%) 400,729 (19.9%)
Age, years, median (IQR) 67 (59, 72) 66 (56, 72) < 0.001
Age (category) < 0.001
<40 49,727 (3.1%) 19,289 (4.8%)
40–49 66,806 (4.1%) 23,398 (5.8%)
50–59 320,447 (19.8%) 87,451 (21.8%)
60–69 578,090 (35.7%) 117,444 (29.3%)
≥70 602,944 (37.3%) 153,147 (38.2%)
Sex < 0.001
Female 120,946 (7.5%) 36,399 (9.1%)
Male 1,497,068 (92.5%) 364,330 (90.9%)
Race < 0.001
White 1,160,450 (77.1%) 276,782 (74.6%)
Black 323,822 (21.5%) 84,555 (22.8%)
Other 20,312 (1.4%) 9,905 (2.7%)
Ethnicity -Latino 93,555 (6%) 25,037 (6.5%) < 0.001
Location < 0.001
Inpatient 10,510 (0.6%) 3,346 (0.8%)
Outpatient 1,607,504 (99.4%) 397,383 (99.2%)
Procedure < 0.001
Prostate biopsy 31,242 (1.9%) 8,670 (2.2%)
Chest CT scan 579,748 (35.8%) 138,139 (34.5%)
Cystoscopy 83,437 (5.2%) 22,058 (5.5%)
Colonoscopy 923,587 (57.1%) 231,862 (57.9%)

Numbers represent frequency (%) unless otherwise specified. Other race represents Asian, American Indian, Pacific Islander, or Unknown. IQR-interquartile range, CT-computed tomography.